United Therapeutics Corporation (UTHR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 21.59B |
| Enterprise Value | 20.07B |
| P/E Ratio | 16.73 |
| PEG Ratio | 1.84 |
| Price/Sales Ratio | 6.8 |
| Price/Book Ratio | 3.37 |
| Enterprise/Revenue | 6.23 |
| Enterprise/EBITDA | 11.9 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.42 |
| Operating Margin | 0.44 |
| Return On Assets | 0.18 |
| Return On Equity | 0.2 |
| Revenue | 3.18B |
| Revenue/Share | 74.05 |
| Gross Profit | 2.8B |
| EBITDA | 1.82B |
| Net Income | 1.33B |
| Diluted EPS | 27.86 |
| Total Cash | 2.66B |
| Total Cash/Share | 62.5 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 5.73 |
| Book Value Per Share | 150.24 |
| 52-Week Change | 24.89 |
| 52-Week High | 609.35 |
| 52-Week Low | 396.12 |
| Moving Average 50 Days | 524.03 |
| Moving Average 200 Days | 523.71 |
| Average Volume | 520,332 |
| Shares Outstanding | 42.45M |
| % Held by Institutions | 98.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | September 23, 2009 |